66 results
8-K
EX-99.2
VIR
Vir Biotechnology Inc
6 Jul 20
Our mission is to create a world without infectious disease
6:32am
or indirectly, to federal and state healthcare fraud and abuse laws, false claims laws, health information privacy and security laws, and other healthcare … laws and regulations. If we are unable to comply, or have not fully complied, with such laws, we could face substantial penalties.
Healthcare providers
8-K
EX-99.1
VIR
Vir Biotechnology Inc
27 May 21
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives
4:55pm
. while the pandemic remains a public health emergency. The FDA Fact Sheet for Healthcare Providers regarding the emergency use of sotrovimab reflects … with the intent that all appropriate patients will have access to it, with little to no out-of-pocket costs. Patients and healthcare professionals can access more
10-Q
2019 Q3
VIR
Vir Biotechnology Inc
19 Nov 19
Quarterly report
4:06pm
approval.
Our relationships with customers, physicians, and third-party payors are subject, directly or indirectly, to federal and state healthcare … fraud and abuse laws, false claims laws, health information privacy and security laws, and other healthcare laws and regulations. If we are unable
DRS
VIR
Vir Biotechnology Inc
27 Jun 19
Draft registration statement
12:00am
, to federal and state healthcare fraud and abuse laws, false claims laws, health information privacy and security laws, and other healthcare laws … and regulations. If we are unable to comply, or have not fully complied, with such laws, we could face substantial penalties.
Healthcare providers
8-K
EX-99.1
4smwn8j
25 Mar 22
Other Events
4:10pm
424B4
ufq4 g8o87vy
11 Oct 19
Prospectus supplement with pricing info
5:31pm
DRS/A
pqo6sdxma3m
7 Aug 19
Draft registration statement (amended)
12:00am
10-K
eaedblf7 lc1gak
26 Mar 20
Annual report
4:08pm
S-1
4cogaa9x85f5bgi42vim
3 Sep 19
IPO registration
4:40pm
S-1/A
3ywv4ks607ruc5y2j
30 Sep 19
IPO registration (amended)
6:12am